Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06455462
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-03-01
Brief Title:
Patient Characteristics Treatment Patterns and Outcomes of Patients Enrolled in the Tezepelumab Patient Access Programme a Retrospective Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D5180R00027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None